Pacira BioSciences (PCRX) EBITDA (2010 - 2026)
Pacira BioSciences' EBITDA came in at $25.56 million for Q2 2026, down 28.6% from $35.82 million a year earlier and down 9.5% from the prior quarter.
Powered by 
Analysis
Pacira BioSciences (PCRX) EBITDA (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Pacira BioSciences reported EBITDA of $105.03 million; for FY2025, it came in at $110.21 million.
- EBITDA carries a five-year compound annual growth rate of 10.7% (FY2020 to FY2025).
- Going back by year, EBITDA was $5.41 million in FY2024 (-96.7%), $163.25 million in FY2023 (+7.7%), $151.53 million in FY2022 (+27.9%) and $118.47 million in FY2021 (+78.8%).
- The five-year range for quarterly EBITDA is -$119.27 million (Q3 2024) to $58.93 million (Q2 2023).
- Year-over-year, EBITDA increased in 1 of the last six quarters, with an average decline of 19.5%.
- The fastest year-over-year change in EBITDA over five years came in Q4 2023 (growth of 151.8%), and the weakest in Q1 2023 (a decline of 55.9%).
- Business Quant data shows PCRX's EBITDA at $28.23 million (Q1 2026), $23.68 million (Q4 2025) and $27.55 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Pacira BioSciences | 1.43 Bn | 495.69 Mn | 148.24 Mn | 26.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.08 Mn |
| Mar 31, 2026 | 28.81 Mn |
| Dec 31, 2025 | 24.36 Mn |
| Sep 30, 2025 | 28.18 Mn |
| Jun 30, 2025 | 36.67 Mn |
| Mar 31, 2025 | 24.03 Mn |
| Dec 31, 2024 | 46.89 Mn |
| Sep 30, 2024 | -118.43 Mn |
| Jun 30, 2024 | 47.87 Mn |
| Mar 31, 2024 | 32.32 Mn |
| Dec 31, 2023 | 53.09 Mn |
| Sep 30, 2023 | 36.84 Mn |
| Jun 30, 2023 | 59.62 Mn |
| Mar 31, 2023 | 17.45 Mn |
| Dec 31, 2022 | 21.96 Mn |
| Sep 30, 2022 | 42.18 Mn |
| Jun 30, 2022 | 52.81 Mn |
| Mar 31, 2022 | 38.61 Mn |
| Dec 31, 2021 | 23.19 Mn |
| Sep 30, 2021 | 43.01 Mn |
API Access
Pacira BioSciences EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();